Key Findings:  Results of this trial suggest that Δ8 -THCV may be a novel approach therapeutic approach for nicotine dependence. In addition, researchers suggest that THCV's ought to be tested for other potential anti-addiction efficacies.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  China, United States
Year of Pub:  2019
Cannabinoids Studied:  Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source:  Not Applicable
Citation:  Xi ZX, et al. Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence. Br J Pharmacol. 2019; 176:4773-4784. doi: 10.1111/bph.14844
Authors:  Xi ZX, Muldoon P, Wang XF, Bi GH, Damaj MI, Lichtman AH, Pertwee RG, Gardner EL